
AVORO CAPITAL ADVISORS LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | TSHA | 21.70M | $70.96M |
![]() | FOLD | 15.03M | $118.40M |
![]() | APLS | 12.22M | $276.59M |
![]() | ARWR | 10.90M | $375.94M |
![]() | CNTA | 10.81M | $262.10M |
![]() | OCUL | 10.25M | $119.82M |
![]() | RNA | 7.64M | $333.09M |
![]() | ETNB | 6.39M | $93.90M |
![]() | KYMR | 6.35M | $359.41M |
![]() | VERA | 6.21M | $180.46M |
![]() | XENE | 5.40M | $216.81M |
![]() | GPCR | 5.16M | $144.36M |
![]() | ASND | 5.11M | $1.02B |
![]() | MNKD | 4.47M | $24.00M |
![]() | QURE | 4.44M | $259.42M |
![]() | AKRO | 3.96M | $187.81M |
![]() | MRUS | 3.54M | $333.53M |
![]() | KRYS | 2.78M | $490.36M |
![]() | SLNO | 2.58M | $174.26M |
![]() | TRML | 2.56M | $122.23M |

Taysha Gene Therapies, Inc.
TSHA
Shares Held
21.70M
Value
$70.96M

Amicus Therapeutics, Inc.
FOLD
Shares Held
15.03M
Value
$118.40M

Apellis Pharmaceuticals, Inc.
APLS
Shares Held
12.22M
Value
$276.59M

Arrowhead Pharmaceuticals, Inc.
ARWR
Shares Held
10.90M
Value
$375.94M

Centessa Pharmaceuticals plc
CNTA
Shares Held
10.81M
Value
$262.10M

Ocular Therapeutix, Inc.
OCUL
Shares Held
10.25M
Value
$119.82M

Avidity Biosciences, Inc.
RNA
Shares Held
7.64M
Value
$333.09M

89bio, Inc.
ETNB
Shares Held
6.39M
Value
$93.90M

Kymera Therapeutics, Inc.
KYMR
Shares Held
6.35M
Value
$359.41M

Vera Therapeutics, Inc.
VERA
Shares Held
6.21M
Value
$180.46M

Xenon Pharmaceuticals Inc.
XENE
Shares Held
5.40M
Value
$216.81M

Structure Therapeutics Inc.
GPCR
Shares Held
5.16M
Value
$144.36M

Ascendis Pharma A/S
ASND
Shares Held
5.11M
Value
$1.02B

MannKind Corporation
MNKD
Shares Held
4.47M
Value
$24.00M

uniQure N.V.
QURE
Shares Held
4.44M
Value
$259.42M

Akero Therapeutics, Inc.
AKRO
Shares Held
3.96M
Value
$187.81M

Merus N.V.
MRUS
Shares Held
3.54M
Value
$333.53M

Krystal Biotech, Inc.
KRYS
Shares Held
2.78M
Value
$490.36M

Soleno Therapeutics, Inc.
SLNO
Shares Held
2.58M
Value
$174.26M

Tourmaline Bio, Inc.
TRML
Shares Held
2.56M
Value
$122.23M
